What are the main reasons MAOIs are underutilized in psychiatric practice despite their proven efficacy for certain conditions? What are the key dietary restrictions patients must follow when taking MAOIs? What are the critical drug-drug interactions clinicians must be aware of when prescribing MAOIs? What clinical pearls or tips would you give to clinicians looking to become more comfortable using these agents?

Brought to you by the NEI Podcast, the PsychopharmaStahlogy Show tackles the most novel, exciting, and controversial topics in psychopharmacology in a series of themes. This theme is on underutilized psychotropic drugs.

Today, Dr. Andy Cutler interviews Dr. Thomas Schwartz and Dr. Stephen Stahl about factors that have led to the underutilization of MAOIs in psychiatry.

Let’s listen to Part 2 of our theme: Underutilized Psychiatric Drugs.

Subscribe to the NEI Podcast, so that you don’t miss another episode!

Resources

Email roundtable@maoiexperts.topicbox.com for guidance on prescribing MAO inhibitors

The Prescriber's Guide to Classic MAO Inhibitors (Phenelzine, Tranylcypromine, Isocarboxazid) for Treatment-Resistant Depression

Practical Guide for Prescribing MAOIs: Debunking Myths and Removing Barriers

E230 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: MAOIs with Dr. Thomas Schwartz 51:31 Share

NEI Podcast

Shownotes Transcript

E230 - The PsychopharmaStahlogy Show: Underutilized Psychiatric Drugs: MAOIs with Dr. Thomas Schwartz